Cargando…
The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease
BACKGROUND: The use and effectiveness of hematopoietic stem cell transplantation (HSCT) are limited by lethal complications, i.e., acute and chronic graft-versus-host disease (aGVHD and cGVHD, respectively), in which immune cells from the donor attack healthy recipient tissues. GVHD presents both pr...
Autores principales: | Zhao, Lu, Chen, Shanquan, Yang, Panxin, Cao, Hongcui, Li, Lanjuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6588914/ https://www.ncbi.nlm.nih.gov/pubmed/31227011 http://dx.doi.org/10.1186/s13287-019-1287-9 |
Ejemplares similares
-
A pooled analysis of mesenchymal stem cell-based therapy for liver disease
por: Zhao, Lu, et al.
Publicado: (2018) -
Pulmonary graft-versus-host disease after autologous hematopoietic stem cell transplantation
por: Choi, Sue In, et al.
Publicado: (2016) -
Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: Graft- versus -host disease
por: Pereira, Andréa Z, et al.
Publicado: (2020) -
Efficacy and safety of mesenchymal stem cells treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation
por: Shen, Meng-Zhu, et al.
Publicado: (2022) -
Sinunasal ultrastructure of the transplant hematopoietic stem cell and chronic graft-versus-host disease with rhinosinusitis
por: Ortiz, Erica, et al.
Publicado: (2013)